Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Inducible MyD88 Signaling Enhances the Anti-AML Activity of BiTE-Secreting ENG T-Cells

Abishek Vaidya, MS, Erin E Doherty, MD, Xiya Wu, Challice L. Bonifant, MD PhD, Stephen Gottschalk, MD, Mireya Paulina Velasquez, MD

Blood (2019) 134 (Supplement_1): 4441.

https://doi.org/10.1182/blood-2019-125395

Published: 2019

Journal Articles

Single Cell Transcriptome Analysis of GATA2 Deficiency in Hematopoiesis Modeled with Induced Pluripotent Stem Cells

Francis Guitart, BA, Moonjung Jung, MD, Stefan Cordes, MD PhD, Shiqin Yu, Jizhong Zou, So Gun Hong, PhD, Vinh Dang, Diego A Espinoza, BA, Amy Hsu, Steven M. Holland, MD, Danielle M. Townsley, MD MSc, Cynthia E. Dunbar, MD, Thomas Winkler, MD

Blood (2018) 132 (Supplement 1): 5087.

https://doi.org/10.1182/blood-2018-99-118410

Published: 2018

Journal Articles

Inducible MyD88/CD40 (iMC) Costimulation Enhances Polyclonal Epstein-Barr Virus-Specific Cytotoxic T Lymphocyte (EBV-CTL) Proliferation and Anti-Tumor Activity

Mariam Khalil, Eric Yvon, S., Aruna Mahendravada, David M. Spencer, Aaron Foster

Blood (2017) 130 (Supplement 1): 3337.

https://doi.org/10.1182/blood.V130.Suppl_1.3337.3337

Published: 2017

Journal Articles

Dual-Switch CAR-T Cells: Orthogonal Molecular Switches to Control Activation and Elimination of CAR-T Cells to Target CD123 + Cancer

J. Henri Bayle, PhD, MyLinh T Duong, PhD, An Lu, Eva Morschl, PhD, Matthew R. Collinson-Pautz, PhD, Kelly L Sharp, Slawomir Szymanski, PhD, Mary E. Brandt, Kevin M. Slawin, MD, Steven Toler, PhD, Eric Yvon, S., Aaron Foster, David M. Spencer

Blood (2017) 130 (Supplement 1): 3184.

https://doi.org/10.1182/blood.V130.Suppl_1.3184.3184

Published: 2017

Journal Articles

Dominant Negative Form of PAX5 Is Generated by Multimerization of Its DNA Binding Domain

Norihiko Kawamata, Mario Pennella, Jennifer Woo, Arnold Berk, H. Phillip Koeffler, MD

Blood (2010) 116 (21): 25.

https://doi.org/10.1182/blood.V116.21.25.25

Published: 2010

Journal Articles

Response to Dasatinib In Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Correlates with p-Lyn and p-Syk

Philip C. Amrein, MD, Eyal C Attar, MD, Tak Takvorian, M.D., Ephraim Hochberg, Karen K Ballen, MD, Kathleen M Leahy, David C. Fisher, MD, Ann LaCasce, MD, MSc, Eric D Jacobsen, MD, Philippe Armand, MD, PhD, Robert Hasserjian, MD, Lillian Werner, Donna Neuberg, ScD, Jennifer R Brown, MD, PhD

Blood (2010) 116 (21): 2457.

https://doi.org/10.1182/blood.V116.21.2457.2457

Published: 2010

Journal Articles

Phase I Trial of Lenalidomide and CCI-779 in Patients with Relapsed Multiple Myeloma.

Craig C Hofmeister, M.D., Don Benson, MD, PhD, Yvonne A Efebera, M.D., Sherif Farag, MBBS, PhD, Michael R. Grever

Blood (2009) 114 (22): 2884.

https://doi.org/10.1182/blood.V114.22.2884.2884

Published: 2009

Journal Articles

The Homodimeric Hematopoietic Cytokine Receptor C-Mpl Requires Cross Phosphorylation in Order to Signal Cell Proliferation

Justin Persico, MD, Imawati Budjahardo, MD, PhD, Kenneth Kaushansky, MD

Blood (2008) 112 (11): 3734.

https://doi.org/10.1182/blood.V112.11.3734.3734

Published: 2008

Journal Articles

Transforming Activity of AML1-ETO Oncoprotein Is Independent of CBFβ and ETO but Requires Homo-Oligomeric Interaction.

Bernd B Zeisig, PhD, Colin Kwok, PhD, Jihui Qiu, PhD, Shuo Dong, MD, Chi Wai Eric So, PhD

Blood (2008) 112 (11): 3348.

https://doi.org/10.1182/blood.V112.11.3348.3348

Published: 2008

Journal Articles

Influence of mTOR Signalling Pathway on the MHC I Immunopeptidome.

Marie-Hélène Fortier, Etienne Caron, Danielle De Verteuil, Claude Perreault, MD, Pierre Thibault, PhD

Blood (2007) 110 (11): 3887.

https://doi.org/10.1182/blood.V110.11.3887.3887

Published: 2007

Journal Articles

Recruitment of RXRα by Homo-Oligomeric RARα Is a Key for RARα-Mediated Transformation.

Bernd B. Zeisig, PhD, Colin Kwok, PhD, Amanda J. Wilson, BSc, Arthur Zelent, PhD, Hinrich Gronemeyer, PhD, Shuo Dong, MD PhD, Chi Wai Eric So, PhD

Blood (2006) 108 (11): 360.

https://doi.org/10.1182/blood.V108.11.360.360

Published: 2006

Journal Articles

Self-Association Contributes to E2a-Pbx1-Mediated Oncogenesis.

Zhong Wang, PhD, Michael L. Cleary, MD

Blood (2005) 106 (11): 2611.

https://doi.org/10.1182/blood.V106.11.2611.2611

Published: 2005

Journal Articles

An inducible caspase 9 safety switch for T-cell therapy

Karin C. Straathof, Martin A. Pulè, Patricia Yotnda, Gianpietro Dotti, Elio F. Vanin, Malcolm K. Brenner, Helen E. Heslop, David M. Spencer, Cliona M. Rooney

Blood (2005) 105 (11): 4247–4254.

https://doi.org/10.1182/blood-2004-11-4564

Published: 2005

Includes: Supplemental data

Journal Articles

RNA Expression Levels of (Co)Chaperone Molecules of the Glucocorticoid Receptor Are Not Related to In Vitro Prednisolone Resistance in Childhood ALL.

Wim Tissing, MD, Jules P.P. Meijerink, PhD, Monique L. den Boer, PhD, Bas Brinkhof, Rob Pieters, MD, PhD

Blood (2004) 104 (11): 4485.

https://doi.org/10.1182/blood.V104.11.4485.4485

Published: 2004

Journal Articles

Multiple Myeloma Oncogene 1 (MUM1)/Interferon Regulatory Factor 4 (IRF4) Upregulates Monokine Induced by Interferon-gamma (MIG) Gene Expression in B-Cell Malignancy.

Shinsuke Iida, M.D., Miyuki Uranishi, M.D., Ph.D., Takaomi Sanda, M.D., Takashi Ishida, M.D., Emi Tajima, M.D., Masato Ito, M.D., Ph.D., Hirokazu Komatsu, M.D., Hiroshi Inagaki, M.D., Ryuzo Ueda, M.D.

Blood (2004) 104 (11): 1111.

https://doi.org/10.1182/blood.V104.11.1111.1111

Published: 2004

Journal Articles

In Vivo Drug-Response in Patients with Leukemic Non-Hodgkin’s Lymphomas Is Predicted by In Vitro Chemosensitivity Testing and Gene Expression Profiling.

Kai Uwe Chow, MD, Daniel Nowak, Soo-Zin Kim, MD, Bernd Schneider, Martina Komor, Simone Boehrer, MD, Paris S. Mitrou, MD, Dieter Hoelzer, Eckhart Weidmann, Wolf-Karsten Hofmann

Blood (2004) 104 (11): 2273.

https://doi.org/10.1182/blood.V104.11.2273.2273

Published: 2004

Journal Articles

Inducible Caspase 9 as a Safety Switch in Genetically Modified Cytotoxic T Cells.

Karin C. Straathof, MD, Martin A. Pule, MD, Patricia Yotnda, PhD, Gianpietro Dotti, MD, Elio F. Vanin, PhD, Malcolm K. Brenner, MD, PhD, Helen E. Heslop, MD, PhD, David M. Spencer, PhD, Cliona M. Rooney, PhD

Blood (2004) 104 (11): 1743.

https://doi.org/10.1182/blood.V104.11.1743.1743

Published: 2004

Journal Articles

Sirolimus and tacrolimus binding proteins: double-edged swords for GVHD prophylaxis

Hans-Peter Kiem, Claudio Anasetti

Blood (2003) 102 (5): 1562.

https://doi.org/10.1182/blood-2003-06-2178

Published: 2003

Journal Articles

Receptor specificity in the self-renewal and differentiation of primary multipotential hemopoietic cells

Hui Zeng, Masayoshi Masuko, Liqing Jin, Tobias Neff, Kevin G. Otto, C. Anthony Blau

Blood (2001) 98 (2): 328–334.

https://doi.org/10.1182/blood.V98.2.328

Published: 2001

Journal Articles

Cell proliferation through forced engagement of c-Kit and Flt-3

Kevin G. Otto, Liqing Jin, David M. Spencer, C. Anthony Blau

Blood (2001) 97 (11): 3662–3664.

https://doi.org/10.1182/blood.V97.11.3662

Published: 2001

NARROW

Inducible MyD88 Signaling Enhances the Anti-AML Activity of BiTE-Secreting ENG T-Cells

Single Cell Transcriptome Analysis of GATA2 Deficiency in Hematopoiesis Modeled with Induced Pluripotent Stem Cells

Inducible MyD88/CD40 (iMC) Costimulation Enhances Polyclonal Epstein-Barr Virus-Specific Cytotoxic T Lymphocyte (EBV-CTL) Proliferation and Anti-Tumor Activity

Dual-Switch CAR-T Cells: Orthogonal Molecular Switches to Control Activation and Elimination of CAR-T Cells to Target CD123 + Cancer

Dominant Negative Form of PAX5 Is Generated by Multimerization of Its DNA Binding Domain

Response to Dasatinib In Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Correlates with p-Lyn and p-Syk

Phase I Trial of Lenalidomide and CCI-779 in Patients with Relapsed Multiple Myeloma.

The Homodimeric Hematopoietic Cytokine Receptor C-Mpl Requires Cross Phosphorylation in Order to Signal Cell Proliferation

Transforming Activity of AML1-ETO Oncoprotein Is Independent of CBFβ and ETO but Requires Homo-Oligomeric Interaction.

Influence of mTOR Signalling Pathway on the MHC I Immunopeptidome.

Recruitment of RXRα by Homo-Oligomeric RARα Is a Key for RARα-Mediated Transformation.

Self-Association Contributes to E2a-Pbx1-Mediated Oncogenesis.

An inducible caspase 9 safety switch for T-cell therapy

RNA Expression Levels of (Co)Chaperone Molecules of the Glucocorticoid Receptor Are Not Related to In Vitro Prednisolone Resistance in Childhood ALL.

Multiple Myeloma Oncogene 1 (MUM1)/Interferon Regulatory Factor 4 (IRF4) Upregulates Monokine Induced by Interferon-gamma (MIG) Gene Expression in B-Cell Malignancy.

In Vivo Drug-Response in Patients with Leukemic Non-Hodgkin’s Lymphomas Is Predicted by In Vitro Chemosensitivity Testing and Gene Expression Profiling.

Inducible Caspase 9 as a Safety Switch in Genetically Modified Cytotoxic T Cells.

Sirolimus and tacrolimus binding proteins: double-edged swords for GVHD prophylaxis

Receptor specificity in the self-renewal and differentiation of primary multipotential hemopoietic cells

Cell proliferation through forced engagement of c-Kit and Flt-3

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only